4th Quarter - Termination
FABIANI & COMPANY for REMPEX PHARMACEUTICALS, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Firm
Client
Income
$30,000
Expenses
—
Terminated
Oct 31, 2012
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Termination (this page) | Jan 22, 2013 | $30,000 | Replaced |
| 4th Quarter - Termination Amendment (No Activity) | Jan 22, 2013 | $20,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Antibiotics legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BARROWS | — |
| MELISSA DUPREE | — |
Medical/Disease Research/Clinical Labs MED
Antibiotics legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BARROWS | — |
| MELISSA DUPREE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.